1. Home
  2. JCSE vs MBRX Comparison

JCSE vs MBRX Comparison

Compare JCSE & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JE Cleantech Holdings Limited

JCSE

JE Cleantech Holdings Limited

N/A

Current Price

$1.52

Market Cap

7.9M

ML Signal

N/A

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

N/A

Current Price

$8.87

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JCSE
MBRX
Founded
1999
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9M
6.4M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
JCSE
MBRX
Price
$1.52
$8.87
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $240.00
AVG Volume (30 Days)
11.2K
★ 206.0K
Earning Date
10-20-2026
11-20-2026
Dividend Yield
★ 28.85%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.16
52 Week High
$2.50
$12.65

Technical Indicators

Market Signals
Indicator
JCSE
MBRX
Relative Strength Index (RSI) 49.07 80.14
Support Level $1.24 $2.12
Resistance Level $1.64 $10.24
Average True Range (ATR) 0.12 0.99
MACD -0.01 0.16
Stochastic Oscillator 17.65 72.00

Price Performance

Historical Comparison
JCSE
MBRX

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company has two operating segments namely sale of cleaning systems and other equipment and provision of centralized dishware washing and general cleaning services. Geographically, the company derives a majority of its revenue from Singapore.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Share on Social Networks: